US4364401012 - Common Stock
HOLOGIC INC
NASDAQ:HOLX (10/11/2024, 8:04:38 PM)
After market: 79.81 0 (0%)79.81
-0.11 (-0.14%)
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,990 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752
P: 15082632900
CEO: STEPHEN P. MACMILLAN
Employees: 6990
Website: https://www.hologic.com/
Hologic enters Breast Cancer Awareness Month with the launch of the BustTheMyth campaign. This campaign is aimed at busting myths regarding breast health.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here you can normally see the latest stock twits on HOLX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: